Literature DB >> 18035519

Residential cognitive therapy versus residential interpersonal therapy for social phobia: a randomized clinical trial.

Finn-Magnus Borge1, Asle Hoffart, Harold Sexton, David M Clark, John C Markowitz, Freda McManus.   

Abstract

Eighty patients meeting DSM-IV criteria for social phobia were randomly assigned to 10 weeks of residential cognitive therapy (RCT) or residential interpersonal therapy (RIPT). Subjects were assessed at pretreatment, midtreatment, posttreatment, and 1 year after end of treatment. The patients reported chronic, highly comorbid social phobia. Most had tried other treatments without success. Existing individual treatment protocols for cognitive therapy and interpersonal therapy were extensively modified for an integrated group, individual, and residential format. The RCT and RIPT patients improved significantly on the primary outcome measures from pre- to posttreatment. No significant differences were observed between treatments. Patients also completed three weekly secondary outcome measures; on one, social role security, RCT was superior to RIPT. The entire sample reported continued improvement from posttreatment to 1-year follow-up, indicating that improvements were robust. RCT in the present trial was associated with less improvement compared to individual CT in other recent trials.

Entities:  

Mesh:

Year:  2007        PMID: 18035519     DOI: 10.1016/j.janxdis.2007.10.002

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  9 in total

Review 1.  Avoidant Personality Disorder: a Current Review.

Authors:  Anna Weinbrecht; Lars Schulze; Johanna Boettcher; Babette Renneberg
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285

2.  A randomized trial of MBSR versus aerobic exercise for social anxiety disorder.

Authors:  Hooria Jazaieri; Philippe R Goldin; Kelly Werner; Michal Ziv; James J Gross
Journal:  J Clin Psychol       Date:  2012-05-23

Review 3.  Critical review of outcome research on interpersonal psychotherapy for anxiety disorders.

Authors:  John C Markowitz; Joshua Lipsitz; Barbara L Milrod
Journal:  Depress Anxiety       Date:  2014-02-03       Impact factor: 6.505

Review 4.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

5.  Is Interpersonal Psychotherapy Infinitely Adaptable? A Compendium of the Multiple Modifications of IPT.

Authors:  Ellen Frank; Fiona C Ritchey; Jessica C Levenson
Journal:  Am J Psychother       Date:  2014

6.  Optimal treatment of social phobia: systematic review and meta-analysis.

Authors:  John Canton; Kate M Scott; Paul Glue
Journal:  Neuropsychiatr Dis Treat       Date:  2012-05-03       Impact factor: 2.570

7.  Health care utilization and cost after discharge from a mental health hospital; an RCT comparing community residential aftercare and treatment as usual.

Authors:  Eirik Roos; Ottar Bjerkeset; Aslak Steinsbekk
Journal:  BMC Psychiatry       Date:  2018-11-12       Impact factor: 3.630

8.  Effectiveness of Acceptance and Commitment Therapy on Interpersonal Problems and Psychological Flexibility in Female High School Students With Social Anxiety Disorder.

Authors:  Sayedeh Monireh Azadeh; Hamid Kazemi-Zahrani; Mohammad Ali Besharat
Journal:  Glob J Health Sci       Date:  2015-07-12

9.  Early maladaptive schemas impact on long-term outcome in patients treated with group behavioral therapy for obsessive-compulsive disorder.

Authors:  Tor Sunde; Benjamin Hummelen; Joseph A Himle; Liv Tveit Walseth; Patrick A Vogel; Gunvor Launes; Vegard Øksendal Haaland; Åshild Tellefsen Haaland
Journal:  BMC Psychiatry       Date:  2019-10-26       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.